Trial · NCT03459443
Results by group19
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 19 of 19
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline In Composite Biopsy Score At End Of Initial 12-Month Treatment Period | Danicopan | Baseline | 10.6 | Standard Deviation 3.59 | score on a scale |
| Change From Baseline In Composite Biopsy Score At End Of Initial 12-Month Treatment Period | Danicopan | End of 12-Month Initial Treatment Period | 8.0 | Standard Deviation 4.53 | score on a scale |
| Change From Baseline In Composite Biopsy Score At End Of Initial 12-Month Treatment Period | Danicopan | Change from Baseline | -0.9 | Standard Deviation 1.89 | score on a scale |
| Participants With Reduction In Proteinuria At End Of Initial 12-Month Treatment Period | Danicopan | 8 | participants | ||
| Change From Baseline In Proteinuria At End Of Initial 12-Month Treatment Period | Danicopan | Baseline | 4252.28 | Standard Deviation 2684.959 | mg/day |
| Change From Baseline In Proteinuria At End Of Initial 12-Month Treatment Period | Danicopan | End of Initial 12-Month Treatment Period | 3512.63 | Standard Deviation 3335.765 | mg/day |
| Change From Baseline In Proteinuria At End Of Initial 12-Month Treatment Period | Danicopan | Mean Change from Baseline | -671.11 | Standard Deviation 2695.592 | mg/day |
| Percent Change From Baseline In Proteinuria At End Of Initial 12-Month Treatment Period | Danicopan | -17.1 | Standard Deviation 53.17 | percent change | |
| Slope Of Estimated Glomerular Filtration Rate (eGFR) From Baseline To End Of Initial 12-Month Treatment Period | Danicopan | -1.24917 | Standard Deviation 1.811457 | mL/min/1.73 m^2 per month | |
| Change From Baseline In eGFR At End Of Initial 12-Month Treatment Period | Danicopan | Baseline | 90.692 | Standard Deviation 35.4939 | mL/min/1.73 m^2 |
| Change From Baseline In eGFR At End Of Initial 12-Month Treatment Period | Danicopan | End of Initial 12-Month Treatment Period | 81.412 | Standard Deviation 38.3320 | mL/min/1.73 m^2 |
| Change From Baseline In eGFR At End Of Initial 12-Month Treatment Period | Danicopan | Change from Baseline | -9.795 | Standard Deviation 14.3806 | mL/min/1.73 m^2 |
| Participants With Significant Improvement In eGFR Relative To Baseline At End Of Initial 12-Month Treatment Period | Danicopan | 0 | participants | ||
| Change From Baseline in eGFR Over 12 Months of Treatment For Participants Meeting eGFR Inclusion Criteria | Danicopan | Baseline | 90.692 | Standard Deviation 35.4939 | mL/min/1.73 m^2 |
| Change From Baseline in eGFR Over 12 Months of Treatment For Participants Meeting eGFR Inclusion Criteria | Danicopan | End of Initial 12-Month Treatment Period | 81.412 | Standard Deviation 38.3320 | mL/min/1.73 m^2 |
| Change From Baseline in eGFR Over 12 Months of Treatment For Participants Meeting eGFR Inclusion Criteria | Danicopan | Change from Baseline | -9.795 | Standard Deviation 14.3806 | mL/min/1.73 m^2 |
| Change From Baseline In Measured GFR At The End Of The Initial 12-Month Treatment Period | Group not reported | Baseline | |||
| Change From Baseline In Measured GFR At The End Of The Initial 12-Month Treatment Period | Group not reported | End of initial 12-Month Treatment Period | |||
| Change From Baseline In Measured GFR At The End Of The Initial 12-Month Treatment Period | Group not reported | Change from Baseline |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03459443/results